Tue, Mar 3, 2015, 11:38 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Metabolix, Inc. Message Board

  • jeff.blizz jeff.blizz Apr 26, 2013 8:26 AM Flag

    BIO Elects New Chair, Officers, and Board Members

    Looks like Bio have more faith in Eno than we do in this board.
    Members of the Executive Committee of BIO’s Board of Directors for the 2013-2014 term are:

    Mark Skaletsky, Chairman & CEO, Fenway Pharmaceuticals – Board Treasurer
    David Pyott, Chairman, President, & CEO, Allergan – Board Secretary
    Ron Cohen, President & CEO, Acorda Therapeutics – Health Section Vice Chair
    Adam Monroe, President, Novozymes North America, Novozymes– Industrial & Environmental Section (IES) Governing Board Chair
    Rick Eno, President & CEO, Metabolix – IES Governing Board Vice Chair
    Paul Hastings, President & CEO, OncoMed Pharmaceuticals – Emerging Companies Section (ECS) Governing Board Chair
    John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals – ECS Governing Board Vice Chair
    Gerald Steiner, Executive Vice President, Sustainability & Corporate Affairs, Monsanto – Food & Agriculture Section (FAS) Governing Board Chair
    Neal Gutterson, President & CEO, Mendel Biotechnology – FAS Governing Board Vice Chair
    H. Thomas Watkins, (former) Human Genome Sciences/GlaxoSmithKline – Immediate Past Chair
    Ian Clark, CEO & Head North American Commercial Operations Genentech/Roche – At-Large
    Deborah Dunsire, President & CEO, Millennium: The Takeda Oncology Company – At-Large
    Geno Germano, President and General Manager of Speciality Care and Oncology, Pfizer – At-Large
    Perry Karsen, Chief Operations Officer, Celgene – At-Large
    Jonathan Peacock, Executive Vice President & CEO, Amgen – At-Large
    Richard Pops, Chairman & CEO, Alkermes – At-Large
    Jay Siegel, Chief Biotechnology Officer & Head, Global Regulatory Affairs, Janssen Pharmaceuticals, Johnson & Johnson – At-Large
    Steve Sherwin – Chair Emeritus
    The full BIO Board of Directors is comprised of the elected Directors serving on each of BIO’s Section Governing Boards. The newly-elected Board Members from these Sections are:

1.05+0.38(+56.72%)Mar 3 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.